Carcinoma
Study data from University of Miami, Department of Pathology update understanding of carcinoma
Published in Pharma Law Weekly, March 27th, 2007
Current study results from the report, "Use of p63 for distinction of glandular versus squamous lesions in cervicovaginal specimens," have been published. According to recent research from the United States, "Differentiating primary glandular from high-grade squamous intraepithelial lesions (HSIL) that involve endocervical glands is not an uncommon diagnostic problem in liquid-based gynecological cytology. Squamous and atypical glandular cell lesions may show similar cytomorphologic features."
"The aim of this study was to evaluate the use of p63 as a marker of basal and/or squamous cell derivation in this differential diagnosis. Of 59,257 liquid-based cervicovaginal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2007-03-27)
More Articles from Pharma Law Weekly
- Biomedical Engineering
Cytyc Corporation Announces Expiration of Antitrust Waiting Period for Adeza Biomedical Corporation Tender Offer - Burn Care
Researchers at Royal Surrey County Hospital have published new data on burn care - California Nurses Association
California Nurses Association/NNOC Joins AFL-CIO - Cross Country Healthcare, Inc.
Cross Country Healthcare Announces Favorable Adjustment to Fourth Quarter and Full-Year 2006 Net Income and EPS Pursuant to Final Approval of Settlement in California Lawsuit - Diabetes
New Focus for Health Care Reform: Realigning Competition Around Patient Value - DNA Research
First Test Of Rapid Dna Analysis Pioneered By Washington State And Orchid Cellmark Identifies Alleged Child Rapist Within Just Days - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
